Capability
Quantum Surgical: Strategic Analysis of Medical Robotics and European Sovereignty
How does the Epione robotic platform combine imaging, AI and robotics for percutaneous tumor ablation?
Quantum Surgical, a Montpellier-based French deep-tech firm founded in 2017, develops the Epione®. Defence-finance analysis; 15-page sourced DFM PDF report.
Full figures, sources and the complete assessment are in the report — Read the full DFM Analysis →
Part of our Research, Universities & Deep Tech and Defence & Dual-Use Companies coverage →
Original DFM publication · DFM Analysis report · 2025-12-30
Quantum Surgical, a Montpellier-based French deep-tech firm founded in 2017, develops the Epione® robotic platform for minimally invasive tumor ablations . Combining medical imaging, AI, and robotics, Epione assists radiologists in planning and executing percutaneous needle ablations for tumors in the abdomen, chest, and musculoskeletal structures.
The company has rapidly commercialized its technology – it holds CE certification in Europe (covering liver, kidney, pancreas, lung, chest and bone cancers) and FDA clearance in the US for abdominal ablations .
This analysis answers: How does the Epione robotic platform combine imaging, AI and robotics for percutaneous tumor ablation? How mature is the technology given CE and FDA clearances across multiple cancer indications? What partners and markets support commercialisation of the Montpellier firm's medical robotics? What capability gaps and dependencies affect Quantum Surgical's dual-use/sovereignty positioning?
Continue with the full evidence
This public thread is the short analytical version. The full DFM Analysis report adds the underlying figures and data, the complete source base, and the full procurement & capital-market assessment behind this summary.
Need the full document as a standalone file? Buy the full report (PDF) — €299
Annual Professional unlocks the complete archive and DFM Intelligence (2,200+ company profiles) — See plans →
Original DFM analysis
Quantum Surgical: Strategic Analysis of Medical Robotics and European Sovereignty
FAQ
What is Quantum Surgical: Strategic Analysis of Medical Robotics and European Sovereignty?
The company has rapidly commercialized its technology – it holds CE certification in Europe (covering liver, kidney, pancreas, lung, chest and bone cancers) and FDA clearance in the US for abdominal ablations .
Related DFM Platform threads
- Protected Satellite Communications (Operational Priorities) Capability
- Comand AI: AI-Driven Command-and-Control and Operational Planning Capability
- Kongsberg Ferrotech: Subsea Robotics for Europe’s Critical Infrastructure Security Capability
- Microamp Solutions: Enabling Secure 5G and mmWave Technologies for European Defence and Strategic Autonomy Capability
- Sensnet Analytics: European Fiber-Optic Sensing for Critical Infrastructure Security Capability
- Mynaric: Laser Communication Terminals for Secure Space Networks Capability
Explore this category Strategic Autonomy
Professional requests (internal interest signal — not a marketplace; nothing is charged or promised)
See Professional & Institutional Access — plans, group/institutional seats and contact →
Defence Finance Monitor is an analytical and informational product. It does not constitute investment advice, financial advice or a recommendation to buy or sell securities. Subscriptions run on DFM Analysis. Payments for Professional Packs are processed securely by Stripe at checkout.
Professional comments
Join the discussion on DFM Analysis.
Read & subscribe on DFM Analysis →